University of Crete (UOC)
Μελέτη του ρόλου της L-Καρνιτίνης στην παθογένεια της ενδομητρίωσης
Abstract
dc:descriptionAlthough endometriosis establishment and progression is yet not clear, it is generally accepted that the disease arises from the implantation and growth of ectopic endometrial tissue into the peritoneal cavity following retrograde menstruation. Immune alterations include increased number and activation of peritoneal macrophages, decreased T-cell cytotoxicity and increased circulating antibodies. Furthermore, compounds like cytokines and growth factors, as well as other mitogens in the environment of the abdominal cavity are thought to contribute to the development and progression of endometriosis. L-carnitine is an essential substance that is implicated in the process of lipid and carbohydrate metabolism. The present study examined whether administration of L-carnitine to young female mice alters the percentage of immune cells in peritoneal exudates and the uterus as well as the levels of IFN-γ, TNF-α, IL-2, IL-4, IL-6, VEGF, GMCSF and IGF-1 in blood serum, peritoneal fluid and supernatants of uterine cultured cells as tested by immunofluorescence or ELISA techniques, respectively, leading to a pathological disorder resembling human endometriosis. The results showed that, except from infertility, L-carnitine treatment resulted in a significant increase of macrophages and to a lesser degree an increase of T-cells, while elevated levels of IFN-γ and TNF-α were detected in both serum and peritoneal fluid compared to controls. Although the levels of acyl-L-carnitine measured in mouse serum samples were increased, acyl-L-carnitine was decreased in the murine peritoneal fluid samples In order to evaluate whether L-carnitine may aggravate an already established state of endometriosis, an experimental model of the disease was established. Such model was achieved by the peritoneal administration of human endometrium cells from the Ishikawa cell line to young female mice. Immunohistochemical assays defined the sites of endometrial cell implantation detected by HLA-ABC monoclonal antibody as well as the invasiveness of CD90, CD11 positive cells. Simultaneous administration of L-carnitine demonstrated that, compared to mice that received solely human endometrial cells, L-carnitine increased the number of T-lymphocytes and macrophages, as well as the levels of IFN-γ, TNF-α, IL-2, IL-6, GM-CSF and VEGF, a phenomenon that lasted more than 60 days after Ishikawa cell administration, indicating thus a chronic inflammatory situation. The elevated levels of L-carnitine in the peritoneal fluid and not in the serum showed that L-carnitine is probably used by peritoneal cells. These results extended our previous findings indicating that L-carnitine can not only lead to endometriosis establishment but can also aggravate an already established endometriotic state to the female organism. To conclude, the findings analyzed above are relevant to human endometriosis and indicate that exogenous L-carnitine may play a role in the pathophysiology of endometriosis.
Degree
thesis:*- Grantor dc:publisher
- University of Crete (UOC)
- Year dc:date
- 2007
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Dionyssopoulou, Evlambia
- Διονυσοπούλου, Ευλαμπία
Subjects
dc:subject × 20- Ενδομητρίωση
- L-Καρνιτίνη
- Πειραματικό μοντέλο ποντικού
- Λεμφοκύτταρα
- Μακροφάγα
- Κυτταροκίνες
- Αυξητικοί παράγοντες
- Ishikawa Κυτταρική σειρά
- L-Carnitine
- Ishikawa cell line
- Endometriosis
- Mouse experimental model
- Lymphocytes
- Macrophages
- Cytokines
- Growth factors
- Ιατρική και Επιστήμες Υγείας
- Επιστήμες Υγείας
- Medical and Health Sciences
- Health Sciences
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/15711